Real-time enrollment status for this myeloproliferative neoplasms clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 4:48 PM UTC
| NCT Number | NCT06034002 |
| Recruiting Status | Recruiting |
| Condition | Myeloproliferative Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 290 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Incyte Corporation |
| Last Updated on CT.gov | April 17, 2026 (Apr 17, 2026) |
As of August 27, 2026: Clinical trial NCT06034002 is currently recruiting participants. This phase1 study for myeloproliferative neoplasms is actively seeking new participants at 13 locations across the United States. The study is sponsored by Incyte Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06034002 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06034002 was last updated Apr 17, 2026 (April 17, 2026). HelloStudys verifies this status automatically.